PA.01Pennsylvania · Delaware Valley
Consulting in Philadelphia
Philadelphia's economy is built on institutions: the university and hospital systems that dominate its employment, the pharmaceutical corridor across its suburbs, and an asset-management tradition quietly running some of the largest pools of money in the world. Its newest export — cell and gene therapy — was substantially invented in its labs.
The local terrain
What actually drives Philadelphia.
'Eds and meds' is the skeleton — the universities and health systems are the region's largest employers and its research engine, and the discoveries that launched the cell-and-gene-therapy industry came out of Philadelphia labs, seeding a biotech cluster the region is now consolidating. The suburban pharmaceutical corridor, an asset-management base of unusual scale, and a strategic position on the I-95 freight corridor complete the picture.
Institutional economies produce institutional problems: health systems balancing academic mission against operating margin, biotech spinouts crossing from grant funding to commercial discipline, asset managers defending fees in an indexed world. We work those decisions with the seriousness institutions expect and the speed they rarely get.
- Economic anchors
- University & health-system institutional core
- Birthplace market of cell-and-gene therapy
- Suburban pharmaceutical corridor
- Asset-management base of unusual scale
- Metro
- Delaware Valley
- Taxonomy
- PA.01
- Engagement
- Remote + on-site
A note on how we work in Philadelphia. Praxis is an independent, service-area advisory practice led by Evan Dang — we work with Philadelphia companies remotely and on-site as an engagement requires, and we keep no walk-in office in the city. What you engage is the thinking and the work, delivered where the decisions are made.
The sectors that matter here
Where the local economy concentrates.
These are the industries that carry the weight in Philadelphia. Each has its own practice at Praxis — its strategic terrain, the services that fit it, and an honest FAQ.
- 01Academic medicine & biotechHealth systems at institutional scale and a gene-therapy cluster crossing into industry.Healthcare & Medical practice
- 02Asset managementSome of the world's largest pools of money are run from this metro — with fee and product strategy in play.Finance & Insurance practice
- 03Corridor logisticsA freight and distribution position at the center of the Northeast's population spine.Transportation & Logistics practice
Where we start
The services that fit Philadelphia.
- View service
Change management
Transformation inside institutions whose cultures predate the industries disrupting them.
- View service
Innovation consulting
Carrying lab-born science across the commercial gap the region keeps rediscovering.
- View service
Investment-management consulting
Operating advisory for managers of unusual scale — never management of client assets.
- View service
Compliance consulting
Regulatory navigation for businesses living at the intersection of medicine, money, and public trust.
Questions
Working with us in Philadelphia.
- Do you advise health systems and universities, not just companies?
- Yes — institutional clients are a natural fit for the practice: strategy, operating-model, and change work where mission and margin have to be balanced explicitly. We bring corporate-grade rigor calibrated to institutional governance, boards, and time horizons.
- Can you help a biotech spinout cross from grants to commercial funding?
- That crossing is a strategy problem before it's a fundraising problem: what the company sells, to whom, and what the capital actually buys. We build that case — positioning, plan, and financial logic — while your scientific leadership keeps the science honest.
Bring us a decision in Philadelphia.
A first conversation is a scoping conversation — no obligation, no packaged pitch. Tell us what you're deciding, and we'll tell you honestly whether we're the right firm for it.
No obligation · a scoping conversation first